SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-16-007488
Filing Date
2016-02-05
Accepted
2016-02-05 13:41:05
Documents
5
Period of Report
2016-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4784
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 305233
3 EXHIBIT 99.1 exhibit99-2.htm EX-99.2 103899
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 14024
5 GRAPHIC exhibit99-3x3x1.jpg GRAPHIC 2405
  Complete submission text file 0001062993-16-007488.txt   432378
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 161391489
SIC: 2834 Pharmaceutical Preparations